Fuqiang Cui Selected Research

Hepatitis B Vaccines (Hepatitis B Vaccine)

3/2020	A Real-world Prospective Study of Mother-to-child Transmission of HBV in China Using a Mobile Health Application (Shield 01).
1/2019	Hepatitis B vaccination coverage among health care workers in China.
11/2016	Rapid immunization effects of a new type of 60 μg hepatitis B vaccine compared with traditional 20 μg hepatitis B vaccines in adults.
1/2016	Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in China.
8/2015	Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers.
1/2015	Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China.
1/2015	Effectiveness of prevention of mother-to-child transmission practice in three provinces of Southern China.
12/2014	[Antibody persistence following booster vaccination with three doses of hepatitis B vaccines among low-response adults in Zhangqiu county of Shandong province: 24-month of follow-up from 2009].
12/2013	Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.
12/2013	Improving hepatitis B vaccine timely birth dose coverage: lessons from five demonstration projects in China, 2005-2009.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fuqiang Cui Research Topics

Disease

28	Hepatitis B 10/2021 - 07/2009
14	Infections 10/2021 - 10/2012
5	Chronic Hepatitis B 01/2021 - 09/2015
3	COVID-19 06/2022 - 10/2020
3	Hepatitis A (Hepatitis, Infectious) 01/2021 - 01/2009
2	Fever (Fevers) 03/2022 - 01/2014
2	Fibrosis (Cirrhosis) 01/2021 - 07/2019
1	Thrombosis (Thrombus) 04/2022
1	Pain (Aches) 03/2022
1	Poliomyelitis (Polio) 03/2022
1	Whooping Cough (Pertussis) 03/2022
1	Tetanus 03/2022
1	Diabetes Mellitus 10/2021
1	Human Influenza (Influenza) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Congenital Abnormalities (Deformity) 03/2020
1	Disease Progression 07/2019
1	Virus Diseases (Viral Diseases) 01/2017
1	Infant Death 01/2016
1	Hepatitis 01/2014
1	Exanthema (Rash) 01/2014
1	Branchiootic syndrome 11/2013
1	Wounds and Injuries (Trauma) 11/2013

Drug/Important Bio-Agent (IBA)

19	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2021 - 07/2009
16	VaccinesIBA 06/2022 - 01/2009
10	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 03/2020 - 12/2013
4	Antiviral Agents (Antivirals)IBA 01/2021 - 12/2018
4	gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA 01/2016 - 12/2013
3	Hepatitis B e AntigensIBA 01/2021 - 01/2015
3	Immunoglobulins (Immunoglobulin)IBA 03/2020 - 08/2010
3	Immunoglobulin M (IgM)IBA 01/2019 - 12/2013
3	AntigensIBA 09/2015 - 12/2014
3	EnzymesIBA 01/2014 - 07/2009
2	SolutionsIBA 06/2022 - 01/2021
2	AntibodiesIBA 03/2022 - 01/2014
2	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2014
2	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 01/2021 - 01/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2014
2	Hepatitis B Core AntigensIBA 09/2015 - 07/2009
2	ImmunosorbentsIBA 01/2014 - 07/2009
2	hepatitis B hyperimmune globulinIBA 12/2013 - 12/2013
1	Hemagglutinins (Hemagglutinin)IBA 03/2022
1	diphtheria-tetanus-acellular pertussis-Hib-hepatitis B vaccineIBA 03/2022
1	Glucose (Dextrose)FDA LinkGeneric 10/2021
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	Air Pollutants (Pollutants, Air)IBA 01/2021
1	Tenofovir (Viread)FDA Link 06/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Surface Antigens (Surface Antigen)IBA 12/2014
1	Inactivated VaccinesIBA 01/2014
1	Abscisic AcidIBA 11/2013
1	Biological ProductsIBA 11/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2013

Therapy/Procedure

1	Hand Hygiene 10/2020